269 results
Page 3 of 14
8-K
EX-99.1
pfolpwi 0zsscu
3 Nov 14
Other Events
12:00am
8-K
EX-99.1
ub40ou we
9 Oct 14
BioTime, Inc. Closes $31 Million Financing
12:00am
8-K
EX-99.1
wceouxibrpwge
6 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.2
c0rxzbo23l9 ge5xht
6 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.3
fhpyugqspu6 fdrbl0
6 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
pdr9 368n48i8gls
3 Oct 14
Regulation FD Disclosure
12:00am
424B5
2kujj7 9pgl4
3 Oct 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ceymw
1 Oct 14
LifeMap Solutions Adds Chief Technology Officer to Leadership Team
12:00am
8-K
EX-99.1
cs5ue
19 Sep 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
qncu41hos
17 Sep 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
dh0x4nq7pgoza3wd p5
11 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
4876wk9ej6yq bvqdjm
9 Sep 14
BioTime CEO Dr. Michael D. West to Present at Rodman & Renshaw 16th Annual Healthcare Conference
12:00am
8-K
EX-99.1
v1cujr
28 Aug 14
BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of HyStem®-Based Hydrogel for Vocal Fold Scarring
12:00am
8-K
EX-99.1
0f9x7gsu4v
12 Aug 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
r2dt grkxshq
12 Aug 14
BioTime Announces Second Quarter 2014 Results and Recent Developments
12:00am
8-K
EX-99.1
pptgz wua
14 Jul 14
BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer Diagnosis and Therapy
12:00am
8-K
EX-99.1
nivp5t82iz8oh9gd tg3
17 Jun 14
Entry into a Material Definitive Agreement
12:00am